LYON, France, October 2, 2018 /PRNewswire/ -- With this new Viral Vector bioproduction facility, Novasep confirms its leadership position and effectively addresses the growing gene therapy market demand Novasep, a leading supplier of services and technologies for the life...
from PR Newswire: //https://ift.tt/2xS2nwv
No comments:
Post a Comment